4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-16-096102
CIK 0001411158operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:00 PM ET
Size
10.1 KB
Accession
0001209191-16-096102
Insider Transaction Report
Form 4
Bell Graeme
Executive VP and CFO
Transactions
- Award
Common Stock
2016-02-03+5,000→ 11,006 total - Award
Stock Option (right to buy)
2016-02-03+25,299→ 25,299 totalExercise: $78.91Exp: 2026-02-03→ Common Stock (25,299 underlying) - Award
Performance Restricted Stock Units
2016-02-03+5,000→ 5,000 total→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2016.
- [F2]The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date is January 1, 2016.
- [F3]Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and will vest, if at all, based on the achievement of certain specified performance goals.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:00 PM ET
- Size
- 10.1 KB